Senate Panel Once Again Approves 0.1% Fee on 340B Drug Purchases
by Admin | June 15, 2012 6:05 pm
June 15, 2012—The Senate Appropriations Committee has passed a fiscal 2013 spending bill for federal health care programs[1] that would maintain the Office of Pharmacy Affairs’ (OPA) appropriation at its current $4.47 million and supplement it with another $6 million from a 0.1 percent user fee on 340B drug purchases.
In the report that accompanies the bill, the committee commended the Health Resources and Services Administration (HRSA) “for conducting audits of covered entities[2] and recertifying eligibility[3] for all program participants in an effort to ensure 340B program integrity.”
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[4].
Already registered? Click here to login[5]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)
Endnotes:- a fiscal 2013 spending bill for federal health care programs: http://www.appropriations.senate.gov/news.cfm?method=news.view&id=ced39be3-f09e-4d48-9a03-621f3c227a59
- audits of covered entities: https://340binformed.org/2012/06/hrsa-seeking-contractor-to-advise-opa-on-340b-audits/
- recertifying eligibility: https://340binformed.org/2012/05/340b-recertification-includes-strong-compliance-pledge/
- Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
- Click here to login: http://340binformed.org/reader-login/
Source URL: https://340binformed.org/2012/06/senate-panel-once-again-approves-0-1-fee-on-340b-drug-purchases/